These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 8981558)

  • 1. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
    Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
    Pharmacol Res; 1996; 34(1-2):65-72. PubMed ID: 8981558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect parasympathomimetic activity of the class III antiarrhythmic substance D/L-sotalol in vitro: reversible inhibition of cholinesterase isoenzymes from blood and the human central nervous system.
    Chemnitius JM; Schahmirzadi F; Gonska BD; Kreuzer H; Zech R
    Pharmacol Res; 1996; 34(5-6):193-200. PubMed ID: 9076843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mipafox differential inhibition assay for heart muscle cholinesterases: substrate specificity and inhibition of three isoenzymes by physostigmine and quinidine.
    Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
    Gen Pharmacol; 1997 Apr; 28(4):567-75. PubMed ID: 9147026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by mipafox.
    Petroianu G; Kühn F; Arafat K; Zuleger K; Missler A
    J Appl Toxicol; 2004; 24(2):143-6. PubMed ID: 15052610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metoclopramide and ranitidine on the inhibition of human AChE by VX in vitro.
    Bartling A; Thiermann H; Szinicz L; Worek F
    J Appl Toxicol; 2005; 25(6):568-71. PubMed ID: 16167316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox).
    Petroianu G; Arafat K; Kosanovic M; Saleh A; Camasamudram V; Hasan MY
    J Appl Toxicol; 2003; 23(6):447-51. PubMed ID: 14635269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by paraoxon.
    Petroianu G; Kühn F; Thyes C; Ewald V; Missler A
    J Appl Toxicol; 2003; 23(1):75-9. PubMed ID: 12518340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.
    al-Jafari AA; Kamal MA; Greig NH; Alhomida AS; Perry ER
    Biochem Biophys Res Commun; 1998 Jul; 248(1):180-5. PubMed ID: 9675107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo effects of dichlorvos on blood cholinesterase activities of cattle.
    Khan AA; Coppock RW; Schuler MM; Lillie LE
    Am J Vet Res; 1988 Jul; 49(7):1184-7. PubMed ID: 3421541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent effect of metoclopramide on cholinesterases and suxamethonium metabolism.
    Kao YJ; Tellez J; Turner DR
    Br J Anaesth; 1990 Aug; 65(2):220-4. PubMed ID: 2223340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature of the inhibition of camel retina acetylcholinesterase (EC 3.1.1.7) activity by tetrahydroaminoacridine.
    al-Jafari AA
    J Ocul Pharmacol Ther; 1996; 12(4):503-14. PubMed ID: 8951687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competition between substrates for acetylcholinesterase and cholinesterase.
    Reiner E; Simeon V
    Biochim Biophys Acta; 1977 Jan; 480(1):137-42. PubMed ID: 831831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoclopramide protection of cholinesterase from paraoxon inhibition.
    Petroianu GA; Hasan MY; Kosanovic M; Vijayasarathy C; Saleh AM
    Vet Hum Toxicol; 2003 Oct; 45(5):251-3. PubMed ID: 14513894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine.
    Petroianu GA; Arafat K; Schmitt A; Hasan MY
    J Appl Toxicol; 2005; 25(1):60-7. PubMed ID: 15669026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Estimation of anticholinesterase activity in reversible inhibitors of cholinesterase hydrolysis].
    Brestkin AP; Kuznetsova LP; Rozengart EV
    Ukr Biokhim Zh (1978); 1994; 66(1):66-72. PubMed ID: 7974841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of human erythrocyte acetylcholinesterase inhibition by cis-diamminediaquaplatinum (II).
    Kamal MA
    Anticancer Res; 1997; 17(6D):4487-91. PubMed ID: 9494556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinetics of reversible inhibition of cholinesterases by quaternary diaminoalkyl esters of aromatic dicarboxylic acids].
    Volkova RI; Dmitrieva EN
    Biokhimiia; 1976 Mar; 41(3):443-51. PubMed ID: 1276277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphylation kinetic constants and oxime-induced reactivation in acetylcholinesterase from fetal bovine serum, bovine caudate nucleus, and electric eel.
    Hanke DW; Overton MA
    J Toxicol Environ Health; 1991 Sep; 34(1):141-56. PubMed ID: 1890690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.